PL3041837T3 - Kryształ o specyficznym pokroju kryształu i kompozycja farmaceutyczna zawierająca ten kryształ jako składnik czynny - Google Patents

Kryształ o specyficznym pokroju kryształu i kompozycja farmaceutyczna zawierająca ten kryształ jako składnik czynny

Info

Publication number
PL3041837T3
PL3041837T3 PL14722366T PL14722366T PL3041837T3 PL 3041837 T3 PL3041837 T3 PL 3041837T3 PL 14722366 T PL14722366 T PL 14722366T PL 14722366 T PL14722366 T PL 14722366T PL 3041837 T3 PL3041837 T3 PL 3041837T3
Authority
PL
Poland
Prior art keywords
crystal
pharmaceutical composition
active ingredient
composition containing
habit
Prior art date
Application number
PL14722366T
Other languages
English (en)
Inventor
Takaaki Masuda
Makoto Gotoh
Hideo Kaneda
Original Assignee
Sun Pharma Japan Limited
Nihon Nohyaku Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharma Japan Limited, Nihon Nohyaku Co., Ltd. filed Critical Sun Pharma Japan Limited
Publication of PL3041837T3 publication Critical patent/PL3041837T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016Disaccharides, e.g. lactose, lactulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
PL14722366T 2013-09-06 2014-04-11 Kryształ o specyficznym pokroju kryształu i kompozycja farmaceutyczna zawierająca ten kryształ jako składnik czynny PL3041837T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013185313A JP5680161B1 (ja) 2013-09-06 2013-09-06 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
PCT/JP2014/060993 WO2015033612A1 (en) 2013-09-06 2014-04-11 Crystal having specific crystal habit and pharmaceutical composition containing the crystal as active ingredient
EP14722366.3A EP3041837B1 (en) 2013-09-06 2014-04-11 Crystal having specific crystal habit and pharmaceutical composition containing the crystal as active ingredient

Publications (1)

Publication Number Publication Date
PL3041837T3 true PL3041837T3 (pl) 2022-06-06

Family

ID=50680085

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14722366T PL3041837T3 (pl) 2013-09-06 2014-04-11 Kryształ o specyficznym pokroju kryształu i kompozycja farmaceutyczna zawierająca ten kryształ jako składnik czynny

Country Status (7)

Country Link
US (1) US9527836B2 (pl)
EP (1) EP3041837B1 (pl)
JP (1) JP5680161B1 (pl)
KR (1) KR20160053915A (pl)
CN (1) CN105518002A (pl)
PL (1) PL3041837T3 (pl)
WO (1) WO2015033612A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5951864B1 (ja) * 2015-06-05 2016-07-13 株式会社ポーラファルマ 抗ジアルジア剤
JP2017101009A (ja) 2015-12-04 2017-06-08 株式会社ポーラファルマ 抗アカントアメーバ剤及びその製造法
JP6085706B1 (ja) * 2016-03-31 2017-02-22 株式会社ポーラファルマ 抗トリトリコモナス剤

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60218387A (ja) 1984-04-14 1985-11-01 Nippon Nohyaku Co Ltd ケテンs,s−アセタ−ル類
JP3081766B2 (ja) 1994-05-06 2000-08-28 東興薬品工業株式会社 角質貯留型抗真菌外用組成物
JP3278738B2 (ja) * 1995-07-08 2002-04-30 日本農薬株式会社 抗真菌剤
US5900488A (en) * 1995-07-08 1999-05-04 Nihon Nohyaku Co., Ltd. Method for treating mycosis using imidazolylacetonitrile derivatives
WO2001051919A2 (en) 2000-01-07 2001-07-19 Transform Pharmaceuticals, Inc. High-throughput formation, identification, and analysis of diverse solid-forms
JP2002114680A (ja) 2000-07-31 2002-04-16 Nippon Nohyaku Co Ltd 抗真菌剤
US20070082870A1 (en) * 2005-10-11 2007-04-12 Buchanan Charles M Pharmaceutical formulations of cyclodextrins and antifungal azole compounds
JP5184342B2 (ja) 2006-03-08 2013-04-17 日本農薬株式会社 外用の医薬組成物
KR101373955B1 (ko) 2006-03-08 2014-03-12 니혼노야쿠가부시키가이샤 외용의 의약 조성물
BRPI0621446C1 (pt) 2006-03-08 2021-05-25 Nihon Nohyaku Co Ltd composição farmacêutica para uso externo
HUE029707T2 (en) 2007-08-27 2017-03-28 Nihon Nohyaku Co Ltd Anti-fungal dermatitis
CN101808637B (zh) 2007-09-05 2013-07-24 宝丽制药股份有限公司 医药组合物
EP2191827B1 (en) 2007-09-05 2013-10-30 Pola Pharma Inc. Antifungal composition
CN101808639B (zh) 2007-09-05 2012-12-05 宝丽制药股份有限公司 抗真菌医药组合物
EP2745692A1 (en) 2009-02-13 2014-06-25 Topica Pharmaceuticals, Inc anti-fungal formulation containing luliconazole
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
KR101409792B1 (ko) 2009-04-09 2014-06-19 니혼노야쿠가부시키가이샤 항진균성 약제학적 조성물
WO2011024620A1 (en) 2009-08-25 2011-03-03 Pola Pharma Inc. Antimycotic pharmaceutical composition
EP2579847A1 (en) 2010-06-11 2013-04-17 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN103012385B (zh) * 2012-02-17 2015-07-08 山东威智医药工业有限公司 卢立康唑的晶型及其制备方法
JP5460797B1 (ja) 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
WO2014041708A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal
US20150238606A1 (en) 2012-09-14 2015-08-27 Pola Pharma Inc., Pharmaceutical composition containing luliconazole
US9068958B1 (en) * 2012-09-14 2015-06-30 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and pharmaceutical composition prepared by containing the crystal
WO2014042231A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Crystal and pharmaceutical preparation containing the same crystal
CN104955455A (zh) 2013-01-28 2015-09-30 宝丽制药股份有限公司 针对由病原微生物诸如曲霉引起的疾病的药物组合物
EP2948146A1 (en) 2013-01-28 2015-12-02 Pola Pharma Inc. Pharmaceutical composition for diseases caused by pathogenic microorganisms such as candida
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP2016518306A (ja) 2013-05-17 2016-06-23 株式会社ポーラファルマ アスペルギルス、カンジダ等を病原体とする疾患用の医薬組成物

Also Published As

Publication number Publication date
EP3041837B1 (en) 2021-10-13
JP5680161B1 (ja) 2015-03-04
US20160168136A1 (en) 2016-06-16
JP2015051945A (ja) 2015-03-19
EP3041837A1 (en) 2016-07-13
WO2015033612A1 (en) 2015-03-12
US9527836B2 (en) 2016-12-27
KR20160053915A (ko) 2016-05-13
CN105518002A (zh) 2016-04-20

Similar Documents

Publication Publication Date Title
IL285390A (en) Arylquinazolines, their preparation and pharmaceutical preparations containing them
IL263978B (en) Amorphous latrovir and solid pharmaceutical preparations containing it and its uses
RU2016118771A3 (en) Co-crystals and pharmaceutical compositions comprising the same
IL244206A0 (en) A pharmaceutical preparation containing a pyrimidine compound as an active ingredient
IL240290B (en) History of pyridazinone-amide and pharmaceutical preparations containing them
EP3043824A4 (en) Modified therapeutic agents and compositions thereof
PT3043773T (pt) Composição farmacêutica de dose fixa estável composta por mometasona e olopatadina para administração nasal
ZA201509307B (en) Pharmaceutical composition, preparation and uses thereof
GB2519982B (en) Fungicidal composition and the use thereof
ZA201505318B (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions
EP2976091C0 (de) Antioxidativ wirksame zusammensetzung und deren verwendung
EP3087987A4 (en) Pharmaceutical composition containing palonosetron
PT2988733T (pt) Composição farmacêutica contendo macitentano cristalino
EP2989093A4 (en) NOVEL DERIVATIVES OF TRIAZOLONE OR THEIR SALTS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
IL244693A0 (en) History of piperazine and their use as drugs
IL240875A0 (en) Heterocyclic compounds and pharmaceutical preparations containing them
IL240292B (en) History of quinazoline and pharmaceutical preparations containing them
TWI562776B (en) Pharmaceutical composition and uses thereof
EP3078671A4 (en) Gemcitabine derivative, composition containing the derivative and pharmaceutical use of the derivative
PL3041837T3 (pl) Kryształ o specyficznym pokroju kryształu i kompozycja farmaceutyczna zawierająca ten kryształ jako składnik czynny
GB201307082D0 (en) Pharmaceutical composition comprising 15-HETrE and methods of using the same
EP3087979A4 (en) Sustained-release pharmaceutical composition containing acebrophylline and hydrophobic sustained-release agent
HRP20171815T1 (hr) Stabilni farmaceutski pripravak koji sadrži amorfni rosuvastatin-kalcij
EP3195864A4 (en) Pharmaceutical composition containing an analgesic agent and an antispasmosdic agent
EP3048886A4 (en) 3, 4-bis-benzylsulfonylbutanenitrile and its pharmaceutical use